CS Medica A/S (NGM: CSMED)
Sweden
· Delayed Price · Currency is SEK 1.135
-0.750 (-39.79%)
At close: Dec 23, 2024
CS Medica Income Statement
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 |
| Revenue | 8.46 | 8.46 | 1.07 | 10.58 | 3.18 | 2.11 | Upgrade
|
| Revenue Growth (YoY) | 692.80% | 692.80% | -89.92% | 232.85% | 50.64% | 48.02% | Upgrade
|
| Cost of Revenue | 5.25 | 5.25 | 0.15 | 5.96 | 1.5 | 1.43 | Upgrade
|
| Gross Profit | 3.21 | 3.21 | 0.91 | 4.62 | 1.68 | 0.68 | Upgrade
|
| Selling, General & Admin | 13.58 | 13.58 | 16.9 | 16.62 | 2.47 | 0.91 | Upgrade
|
| Other Operating Expenses | - | - | -0.16 | -0.74 | -1.99 | -0.68 | Upgrade
|
| Operating Expenses | 15.69 | 15.69 | 18.81 | 17.95 | 1.85 | 0.62 | Upgrade
|
| Operating Income | -12.48 | -12.48 | -17.9 | -13.33 | -0.18 | 0.07 | Upgrade
|
| Interest Expense | -1.53 | -1.53 | -0.57 | -0.83 | -0.23 | -0.14 | Upgrade
|
| Earnings From Equity Investments | -0.46 | -0.46 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | 0 | -0 | -0 | 0 | Upgrade
|
| Pretax Income | -14.47 | -14.47 | -18.47 | -14.16 | -0.41 | -0.08 | Upgrade
|
| Income Tax Expense | -4.82 | -4.82 | -3.95 | -3.36 | -1.06 | -0.02 | Upgrade
|
| Net Income | -9.65 | -9.65 | -14.51 | -10.8 | 0.65 | -0.05 | Upgrade
|
| Net Income to Common | -9.65 | -9.65 | -14.51 | -10.8 | 0.65 | -0.05 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 12 | 12 | 5 | - | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 12 | 12 | 5 | - | Upgrade
|
| Shares Change (YoY) | 38.98% | 38.98% | 6.12% | 113.03% | - | - | Upgrade
|
| EPS (Basic) | -0.56 | -0.56 | -1.18 | -0.93 | 0.12 | - | Upgrade
|
| EPS (Diluted) | -0.56 | -0.56 | -1.18 | -0.93 | 0.12 | - | Upgrade
|
| Free Cash Flow | -4.35 | -4.35 | -8.33 | -14.04 | -6.02 | 0.67 | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.25 | -0.68 | -1.21 | -1.10 | - | Upgrade
|
| Gross Margin | 37.92% | 37.92% | 85.60% | 43.66% | 52.72% | 32.34% | Upgrade
|
| Operating Margin | -147.55% | -147.55% | -1677.04% | -125.99% | -5.54% | 3.12% | Upgrade
|
| Profit Margin | -114.06% | -114.06% | -1359.80% | -102.08% | 20.37% | -2.59% | Upgrade
|
| Free Cash Flow Margin | -51.43% | -51.43% | -780.39% | -132.68% | -189.30% | 31.58% | Upgrade
|
| EBITDA | -10.37 | -10.37 | -17.42 | -12.86 | 0.18 | 0.45 | Upgrade
|
| EBITDA Margin | -122.55% | -122.55% | - | -121.47% | 5.65% | 21.34% | Upgrade
|
| D&A For EBITDA | 2.12 | 2.12 | 0.48 | 0.48 | 0.36 | 0.38 | Upgrade
|
| EBIT | -12.48 | -12.48 | -17.9 | -13.33 | -0.18 | 0.07 | Upgrade
|
| EBIT Margin | -147.55% | -147.55% | - | -125.99% | -5.54% | 3.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.